眼科藥物輸送系統市場：按技術、生產技術、材料、輸送途徑分類 - 全球預測 2025-2030

2023年眼科給藥系統市值為163.5億美元，預計2024年將達到178.5億美元，複合年成長率為9.59%，到2030年將達到310.4億美元。

眼科藥物傳輸系統包括多種旨在將藥物輸送到眼睛以治療眼科疾病和疾病的技術和方法。由於眼睛獨特的解剖結構以及在目標區域實現有效藥物濃度的挑戰，該領域在製藥和醫療保健行業中至關重要。對此類系統的需求源於傳統全身給藥方法不足以有效的疾病，例如青光眼、黃斑部病變、乾眼症和術後護理。各種給藥系統，如眼藥水、軟膏、注射和植入，經過客製化以提高生物利用度和患者依從性。典型的最終用戶包括醫院、眼科診所和居家醫療機構。

這個市場主要是由眼科疾病率上升、人口老化以及藥物配方和輸送技術的進步所推動的。奈米技術和生物分解性的藥物釋放型植入等發展改善了治療結果和患者依從性，並為創新提供了有利的機會。然而，成長受到高研發成本、嚴格的監管要求以及限制藥物滲透的眼生物學複雜性等因素的限制。此外，患者的依從性仍然是一個挑戰，特別是需要長期給藥時。

為了利用新的商機，公司應專注於研究並投資新配方，以開發非侵入性且對患者友善的藥物輸送系統。與學術機構和生物技術公司的合作可以刺激輸送機制和材料的創新，擴大治療的可能性。儘管存在挑戰，個人化醫療和數位健康技術整合的進步可以將眼科藥物傳輸系統定位為未來眼科治療的基石。為了在這個快速發展的市場中保持競爭力，適應監管環境和最佳化成本結構至關重要，因為您需要根據技術進步和患者需求不斷發展您的策略。

市場動態：快速發展的眼科給藥系統市場的關鍵市場洞察

供給與需求的動態交互作用正在改變眼科給藥系統市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

• 市場促進因素
  • 人口老化導致眼科疾病增加
  • 人們越來越偏好早期診斷和預防
  • 加大政府在眼部保健方面的力度
• 市場限制因素
  • 眼科給藥系統併發症的發生
• 市場機會
  • 眼科藥物輸送系統的不斷進步
  • 優惠報銷政策
• 市場挑戰
  • 對溶解藥物的低生物利用度和不穩定的擔憂

波特五力：駕馭眼科給藥系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解對眼科給藥系統市場的外部影響

外部宏觀環境因素在塑造眼科給藥系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解眼科給藥系統市場的競爭狀況

對眼科藥物輸送系統市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣眼科給藥系統市場供應商績效評估

FPNV 定位矩陣是評估眼科給藥系統市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定眼科給藥系統市場成功之路的策略分析與建議

對於旨在加強在全球市場的影響力的公司來說，對眼科藥物輸送系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 老年人口眼科疾病增加
    • 對早期診斷和預防的興趣增加
    • 擴大政府在眼部保健上的努力
  • 抑制因素
    • 與眼科藥物傳輸系統相關的併發症
  • 機會
    • 眼科藥物輸送系統的不斷進步
    • 優惠退款政策
  • 任務
    • 對溶解藥物的低生物有效性和不穩定的擔憂
• 市場區隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 經濟
  • 社群
  • 技術的
  • 合法地
  • 環境

第6章眼科給藥系統市場：依技術分類

• 隱形眼鏡
• 植入外層植入物
• 眼藥水
• 水凝膠
• 可注射顆粒系統
• 玻璃體內植入
• 離子電滲
• 微機電
• 微型針
• 奈米載體
• 奈米粒子
• 淚點塞

第7章眼科給藥系統市場生產技術

• 3D列印
• 壓縮成型
• 靜電紡絲
• 擠壓
• 處方
• 微圖形化

第8章眼科給藥系統市場：依材料分類

• 膠原蛋白
• 脂肪酸
• 水凝膠
• 脂質體
• PDO/PVA
• PLA-PEG
• PLGA
• 聚己內酯
• 聚原酸酯
• TMC

第9章眼科藥物傳輸系統市場（依輸送途徑）

• 在前房
• 眼
• 玻璃體內

第10章北美及南美眼科給藥系統市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太眼科給藥系統市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲眼科給藥系統市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭格局

• 2023 年市場佔有率分析
• FPNV 定位矩陣，2023
• 競爭情境分析
• 戰略分析和建議

公司名單

• AptarGroup, Inc.
• Bausch Health Companies Inc.
• Biocorp
• Envisia Therapeutics
• EyePoint Pharmaceuticals, Inc.
• Gerresheimer AG
• Mati Therapeutics, Inc.
• Merck & Co.
• Novartis AG
• Ocular Therapeutix Inc.
• Oculis Pharma
• Owen Mumford
• Pfizer Inc.
• Terumo Corporation
• Teva Pharmaceuticals

The Ophthalmic Drug Delivery System Market was valued at USD 16.35 billion in 2023, expected to reach USD 17.85 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 31.04 billion by 2030.

The ophthalmic drug delivery system encompasses a range of technologies and methods designed to deliver drugs to the eye for treating ocular conditions and diseases. This segment is pivotal in the pharmaceutical and healthcare industry due to the eye's unique anatomy and the challenges in achieving effective drug concentration in targeted areas. The necessity for such systems arises from conditions like glaucoma, macular degeneration, dry eye syndrome, and post-surgical care, where conventional systemic drug delivery methods fall short in efficacy. Various delivery systems, such as eye drops, ointments, injections, and implants, are tailored to improve bioavailability and patient compliance. Key end-users include hospitals, ophthalmic clinics, and homecare settings.

The market is primarily driven by the rising prevalence of eye disorders, an aging population, and advancements in drug formulations and delivery technologies. Developments such as nanotechnology and biodegradable drug-eluting implants present lucrative opportunities for innovation, offering enhanced therapeutic outcomes and patient adherence. However, growth is tempered by factors like high R&D costs, stringent regulatory requirements, and the complex nature of ocular biology that limits drug penetration. Moreover, patient compliance remains a challenge, especially with chronic administration requirements.

To capitalize on emerging opportunities, companies should focus on research to develop non-invasive, patient-friendly delivery systems and invest in novel drug formulations. Collaboration with academic institutions and biotech firms can spur innovation in delivery mechanisms and materials, thus expanding therapeutic potential. Despite existing challenges, advancements in personalized medicine and the integration of digital health technologies could position ophthalmic drug delivery systems as a cornerstone of future ocular therapies. It's crucial for businesses to navigate regulatory landscapes and optimize cost structures to remain competitive in this rapidly evolving market, which requires continuous evolution of strategies aligned with technological progress and patient needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of eye disorders in geriatric population
  • Increasing preference for early diagnosis and prevention
  • Growing government initiatives for eye care
• Market Restraints
  • Associated complications of ophthalmic drug delivery systems
• Market Opportunities
  • Ongoing advancements in ophthalmic drug delivery system
  • Favorable reimbursement policies
• Market Challenges
  • Concern regarding poor bioavailability and instability for dissolved drugs

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Drug Delivery System Market

A detailed market share analysis in the Ophthalmic Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Drug Delivery System Market

A strategic analysis of the Ophthalmic Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include AptarGroup, Inc., Bausch Health Companies Inc., Biocorp, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc., Gerresheimer AG, Mati Therapeutics, Inc., Merck & Co., Novartis AG, Ocular Therapeutix Inc., Oculis Pharma, Owen Mumford, Pfizer Inc., Terumo Corporation, and Teva Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Contact Lenses, Episcleral Implants, Eye Drops, Hydrogels, Injectable Particulate Systems, Intravitreal Implants, Iontophoresis, Micro-Electromechanical, Microneedles, Nano Careers, Nano Microparticles, and Punctal Plugs.
• Based on Production Technology, market is studied across 3D Printing, Compression Molding, Electrospinning, Extrusion, Formulation, and Micro Patterning.
• Based on Material, market is studied across Collagen, Fatty acids, Hydrogels, Liposomes, PDO/PVA, PLA-PEG, PLGA, Polycaprolactone, Polyorthoesters, and TMC.
• Based on Delivery Route, market is studied across Intracameral, Intraocular, and Intravitreal.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of eye disorders in geriatric population
    • 5.1.1.2. Increasing preference for early diagnosis and prevention
    • 5.1.1.3. Growing government initiatives for eye care
  • 5.1.2. Restraints
    • 5.1.2.1. Associated complications of ophthalmic drug delivery systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in ophthalmic drug delivery system
    • 5.1.3.2. Favorable reimbursement policies
  • 5.1.4. Challenges
    • 5.1.4.1. Concern regarding poor bioavailability and instability for dissolved drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Ophthalmic Drug Delivery System Market, by Technology

• 6.1. Introduction
• 6.2. Contact Lenses
• 6.3. Episcleral Implants
• 6.4. Eye Drops
• 6.5. Hydrogels
• 6.6. Injectable Particulate Systems
• 6.7. Intravitreal Implants
• 6.8. Iontophoresis
• 6.9. Micro-Electromechanical
• 6.10. Microneedles
• 6.11. Nano Careers
• 6.12. Nano Microparticles
• 6.13. Punctal Plugs

7. Ophthalmic Drug Delivery System Market, by Production Technology

• 7.1. Introduction
• 7.2. 3D Printing
• 7.3. Compression Molding
• 7.4. Electrospinning
• 7.5. Extrusion
• 7.6. Formulation
• 7.7. Micro Patterning

8. Ophthalmic Drug Delivery System Market, by Material

• 8.1. Introduction
• 8.2. Collagen
• 8.3. Fatty acids
• 8.4. Hydrogels
• 8.5. Liposomes
• 8.6. PDO/PVA
• 8.7. PLA-PEG
• 8.8. PLGA
• 8.9. Polycaprolactone
• 8.10. Polyorthoesters
• 8.11. TMC

9. Ophthalmic Drug Delivery System Market, by Delivery Route

• 9.1. Introduction
• 9.2. Intracameral
• 9.3. Intraocular
• 9.4. Intravitreal

10. Americas Ophthalmic Drug Delivery System Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Ophthalmic Drug Delivery System Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Ophthalmic Drug Delivery System Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AptarGroup, Inc.
• 2. Bausch Health Companies Inc.
• 3. Biocorp
• 4. Envisia Therapeutics
• 5. EyePoint Pharmaceuticals, Inc.
• 6. Gerresheimer AG
• 7. Mati Therapeutics, Inc.
• 8. Merck & Co.
• 9. Novartis AG
• 10. Ocular Therapeutix Inc.
• 11. Oculis Pharma
• 12. Owen Mumford
• 13. Pfizer Inc.
• 14. Terumo Corporation
• 15. Teva Pharmaceuticals

LIST OF FIGURES

• FIGURE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
• FIGURE 2. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EPISCLERAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE PARTICULATE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO-ELECTROMECHANICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO CAREERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO MICROPARTICLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PUNCTAL PLUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COMPRESSION MOLDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTROSPINNING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO PATTERNING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PDO/PVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLA-PEG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYORTHOESTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TMC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRACAMERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 58. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 80. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 81. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 84. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 126. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 130. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 134. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 137. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 138. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 141. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 142. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 145. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 146. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 149. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 150. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 153. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 154. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 157. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 158. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 161. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 162. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 165. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 166. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 169. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 170. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 173. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 174. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 177. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 178. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 181. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 185. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 186. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 189. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 190. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 193. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 194. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 197. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 198. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 201. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 202. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 205. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 206. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 209. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
• TABLE 210. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 211. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023